His research focuses on platelet-derived growth factor receptor (PDGFR) and mitogen-activated protein kinase (MAPK) signaling in normal physiology and cancer. He is an expert in a wide variety of oncogenic signaling pathways, including the SCF/KIT pathway, to which he has made numerous seminal research contributions.